← Back to Patent Explorer
US4526979A Expired / Lapsed US ⏱️ 0.0 years remaining

Carbamates and oxalamides of amino-N-(1H-tetrazol-5-yl)benzamides

Assignee: Aventis Pharmaceuticals Inc
•
Filing: 1983-07-22
•
Granted: 1985-07-02
•
Expires: 2003-07-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Alkoxycarbonyl and oxalyl derivatives of amino-N-(1H-tetrazol-5-yl)benzamides are described herein. The compounds involved are useful as antiallergic agents. These compounds can be prepared by the reaction of an amino-N-(1H-tetrazol-5-yl)benzamide with an appropriate acid chloride.

Inventors

  • 👤 Norton P. Peet
  • 👤 Shyam Sunder

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 08:20
CPC Classifications
C; C07; C07D; C07D257/00; C07D257/02; C07D257/04; C07D257/06; A; A61; A61P; A61P37/00; A61P37/08

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 31 words
A compound of the formula: ##STR4## wherein n is 1 or 2; X is hydrogen or chlorine; and R is alkyl of 1-6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 31 words
A compound of the formula: ##STR4## wherein n is 1 or 2; X is hydrogen or chlorine; and R is alkyl of 1-6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 31 words
A compound according to claim 1 which has the formula: ##STR5## wherein X is hydrogen or chlorine; and R is alkyl of 1-6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 4
Dependent Claim 25 words
A compound according to claim 1 which has the formula: ##STR6## when R is alkyl of 1-6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 5
Dependent Claim 11 words
A compound according to claim 1 which is 2-oxo-N-[2-((1H-tetrazol-5-yl)aminocarbonyl)phenyl]glycine ethyl ester.
Claim 6
Dependent Claim 11 words
A compound according to claim 1 which is 2-oxo-N-[3-((1H-tetrazol-5-yl)aminocarbonyl)phenyl]glycine ethyl ester.
Claim 7
Dependent Claim 11 words
A compound according to claim 1 which is 2-oxo-N-[4-((1H-tetrazol-5-yl)aminocarbonyl)phenyl]glycine ethyl ester.
Claim 8
Dependent Claim 25 words
A compound according to claim 1 which has the formula: ##STR7## wherein R is alkyl of 1-6 carbon atoms; and the pharmaceutically acceptable salts thereof.
Claim 9
Dependent Claim 13 words
A compound according to claim 1 which is [2-((1 H-tetrazol-5-yl)aminocarbonyl)phenyl]carbamic acid ethyl ester.
Claim 10
Dependent Claim 12 words
A compound according to claim 1 which is [3-((1H-tetrazol-5-yl)aminocarbonyl)phenyl]carbamic acid ethyl ester.

References Cited (Backward Citations)

US3824249A Cited
US4176631A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-01 1988-12-31 1989-07-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-01 1992-12-31 1993-07-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-01 1996-12-31 1997-07-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag